This book is dedicated to the development strategy up to the implementation of a new EPI i.e. the HPV vaccination programme in a developing country such as Malaysia. It looks into the economic burden of gynaecological cancers in this country specifically on Cervical Cancer and its' related cervical cancer screening problems in Malaysia. There are step by step flow of economic analysis including the development of their clinical pathways and costs involved from multiple view i.e. the societal perspective.